4-boronophenylalanine has been researched along with boric acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartelink, H; Begg, AC; Gregoire, V; Huiskamp, R; Verrijk, R | 1 |
| Capala, J; Coderre, JA; Makar, MS | 1 |
| Chi, CW; Chou, FI; Chung, HP; Liu, HM; Lui, WY | 1 |
3 other study(ies) available for 4-boronophenylalanine and boric acid
| Article | Year |
|---|---|
Selectivity of boron carriers for boron neutron capture therapy: pharmacological studies with borocaptate sodium, L-boronophenylalanine and boric acid in murine tumors.
Topics: Animals; Boric Acids; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Brain; Dose-Response Relationship, Drug; Female; Half-Life; Injections, Intraperitoneal; Kidney; Liver; Male; Melanoma; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred Strains; Phenylalanine; Radiation-Sensitizing Agents; Sarcoma, Experimental; Sulfhydryl Compounds; Time Factors | 1993 |
Accumulation of boron in malignant and normal cells incubated in vitro with boronophenylalanine, mercaptoborane or boric acid.
Topics: Animals; Boric Acids; Boron; Boron Compounds; Boron Neutron Capture Therapy; Humans; Mice; Phenylalanine; Tumor Cells, Cultured | 1996 |
Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Topics: Animals; Boric Acids; Borohydrides; Boron; Boron Compounds; Boron Neutron Capture Therapy; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Clone Cells; Hepatocytes; Humans; Liver Neoplasms; Phenylalanine; Radiation-Sensitizing Agents; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Tissue Distribution | 2009 |